[1]Patent:EP446604,1991,A2,
[1]Patent:US2001/46991,2001,A1,
[1]BioorganicandMedicinalChemistryLetters,2000,vol.10,#24,p.2825-2828
[1]ArchivderPharmazie,1990,vol.323,p.611-617
75-82-1 | 1,2-Dibromo-1,1-difluoroethane | AA005U17 | MFCD00000369
6969-79-5 | 5-Cyclopentyl-5-methylimidazolidine-2,4-dione | AA005UQ8 | MFCD16830295
767263-33-2 | 4-(Pyridin-2-yl)piperidine-4-carbonitrile | AA005VGY | MFCD18071627
745-62-0 | Prost-13-en-1-oic acid,9,11,15-trihydroxy-, (9a,11a,13E,15S)- | AA005W3G | MFCD00077862
6924-66-9 | Quinoxaline-5-carboxylic acid | AA005WIK | MFCD02854494
71126-73-3 | 6-(Benzyloxy)hexan-1-ol | AA005X9L | MFCD03265790
73733-72-9 | Piperidine, 4-isothiocyanato-1-(phenylmethyl)- | AA005XU9 | MFCD11131104
690632-08-7 | 6-bromo-3H-spiro[1-benzopyran-2,4'-piperidine]-4-one | AA005YGQ | MFCD09262414
690260-90-3 | Ethyl 2-bromo-4-chlorobenzoate | AA005Z3H | MFCD10566824
938458-82-3 | Spiro[2.5]octan-1-ylmethanamine | AA005ZT9 | MFCD09055187